SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2013 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (322)10/10/2013 11:16:27 AM
From: Steve Lokness1 Recommendation

Recommended By
The Ox

  Read Replies (1) | Respond to of 410
 
<<<< The best buy in biotech right now (IMO) is ENTA >>>>>

Care to elaborate? They, like many small biotechs, have as one of their programs the target of resistant bacteria; MRSA and VRE. Companies that are serious about such programs have done well; OPTR and TSRX which were picked up recently by CBST. So is ENTA serious here? And their chances to crack the Hep C virus?